FOCUS-Express Scripts targets new migraine drugs to change U.S. pricing dynamic
April 24, 2018 at 01:00 AM EDT
LOS ANGELES, April 24 (Reuters) - The largest U.S. manager of prescription benefits is telling drugmakers that the current pricing model is broken, and taking aim at Amgen Inc and other makers of new migraine medicines to try and fix it.
